Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · Real-Time Price · USD
4.700
-0.100 (-2.08%)
Jun 27, 2025, 4:00 PM - Market closed
Y-mAbs Therapeutics Market Cap
Y-mAbs Therapeutics has a market cap or net worth of $212.89 million as of June 27, 2025. Its market cap has decreased by -59.81% in one year.
Market Cap
212.89M
Enterprise Value
153.18M
1-Year Change
-59.81%
Ranking
Category
Stock Price
$4.70
Market Cap Chart
Since September 21, 2018, Y-mAbs Therapeutics's market cap has decreased from $796.74M to $212.89M, a decrease of -73.28%. That is a compound annual growth rate of -17.77%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 216.45B |